dc.contributor.author
Seguí Gracia, Nuria
dc.contributor.author
Pineda Riu, Marta
dc.contributor.author
Guinó, Elisabet
dc.contributor.author
Borràs Flores, Ester
dc.contributor.author
Navarro, Matilde
dc.contributor.author
Bellido Molías, Fernando
dc.contributor.author
Moreno Aguado, Víctor
dc.contributor.author
Lázaro García, Conxi
dc.contributor.author
Blanco Guillermo, Ignacio
dc.contributor.author
Capellá, G. (Gabriel)
dc.contributor.author
Valle Velasco, Laura
dc.date.issued
2016-02-03T16:43:32Z
dc.date.issued
2016-02-03T16:43:32Z
dc.date.issued
2013-04-17
dc.date.issued
2016-02-03T16:43:32Z
dc.identifier
https://hdl.handle.net/2445/69223
dc.description.abstract
Telomere length variation has been associated with increased risk of several types of tumors, and telomere shortening, with genetic anticipation in a number of genetic diseases including hereditary cancer syndromes. No conclusive studies have been performed for Lynch syndrome, a hereditary colorectal cancer syndrome caused by germline mutations in the DNA mismatch repair genes. Here we evaluate telomere length in Lynch syndrome, both as a cancer risk factor and as a mechanism associated with anticipation in the age of cancer onset observed in successive generations of Lynch syndrome families. Leukocyte telomere length was measured in 244 mismatch repair gene mutation carriers from 96 Lynch syndrome families and in 234 controls using a monochrome multiplex quantitative PCR method. Cancer-affected mutation carriers showed significantly shorter telomeres than cancer-free mutation carriers. In addition, cancer-affected carriers showed the most pronounced shortening of telomere length with age, compared with unaffected carriers. The anticipation in the age of cancer onset observed in successive generations was not associated with telomere shortening, although, interestingly, all mother-son pairs showed telomere shortening. In conclusion, cancer-affected mismatch repair gene mutation carriers have distinct telomere-length pattern and dynamics. However, anticipation in the age of onset is not explained by telomere shortening. Pending further study, our findings suggest that telomere attrition might explain the previously reported dependence of cancer risk on the parent-of-origin of mismatch repair gene mutations.
dc.format
application/pdf
dc.publisher
Public Library of Science (PLoS)
dc.relation
Reproducció del document publicat a: http://dx.doi.org/10.1371/journal.pone.0061286
dc.relation
PLoS One, 2013, vol. 8, num. 4, p. e61286
dc.relation
http://dx.doi.org/10.1371/journal.pone.0061286
dc.rights
cc-by (c) Seguí Gracia, Núria et al., 2013
dc.rights
http://creativecommons.org/licenses/by/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Càncer colorectal
dc.subject
Genètica humana
dc.subject
Malalties hereditàries
dc.subject
Colorectal cancer
dc.subject
Human genetics
dc.subject
Genetic diseases
dc.title
Telomere length and genetic anticipation in lynch syndrome
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion